Research shows the p-tau217 blood test can indicate very high risk of Alzheimer's disease before symptoms begin, offering ...

High levels of calcium are toxic to cells and contribute to loss of neurons in Alzheimer’s disease. Researchers found that a ...

A new study reveals that obesity accelerated Alzheimer's blood biomarkers by 95% over five years, highlighting a strong ...

Early Alzheimer's patients who completed their course of donanemab therapy by 12 months had cognitive and functional benefits lasting for 2 additional years, reported Jennifer Zimmer, MD, of Eli Lilly ...

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that it has dosed the first subjects in a Phase 1/2a clinical trial of ARO-MAPT, the company’s investigational RNA interference (RNAi) ...

Major Alzheimer’s breakthroughs in 2025 include new FDA-approved blood tests, at-home treatments, and lifestyle research showing cognitive benefits for older adults.

Standing on a purple Walk to End Alzheimer’s stage in front of a crowd holding purple, yellow and orange pinwheel flowers ...

New research published in the journal eNeuro examined whether eliminating a protein that is elevated in the brains of those ...

Brittany Butts understands that for many families, Alzheimer's comes as a double burden. As a teenager, she watched not only ...

Details from two large trials of Novo Nordisk's GLP-1 drug semaglutide showed it provided no cognitive benefit for people ...

GLP-1 drugs, which include Ozempic and Wegovy, have become one of the most closely watched experimental approaches for ...

Alzheimer’s disease accounts for most of the cases of dementia, a condition characterized by progressive or persistent loss ...